Lets get away from the "martis thread" and discuss the business...

Lets get away from the "martis thread" and discuss the business here?

Discussions are on the business model - and investors still seem not to be understanding how the IP model works

Lets open those discussions here - Oslo?

Companies are buying the right to use the Recipe "Mixngo" glue on their products/tests etc

ADO will receive royalties on the customers sales - That costs ADO next to nothing

Where there may be costs is in wages for scientists designated to work on certain partnerships - But as the last investor presentation stated - Our scientists would be charged out at around $250k pa (A very healthy profit to be made here IMO per scientist) - As well as the IP the Anteo scientific team have developed a high level of intangible value to the company through know how taught to them from CSO DR Joe Maeji - This is why share incentives for the staff is a smart idea as these bright young minds have a solid value to the future of the company and for shareholder success.